Methods and Devices for Adrenal Stimulation
OwnerBrett M. Wingeier, Benjamin David Pless +2inventors
InventorsBrett M. Wingeier, Benjamin David Pless, Anthony V. Caparso, Margaret McLaughlin
Life of this patent
Estimating the term…
Abstract
An implantable medical device is provided for the treatment of a variety of disorders. The implantable medical device can be a neurostimulator having a stimulation lead and electrode(s) configured to be implanted on or near neural tissue in communication with the adrenal gland. Application of an electrical waveform to the neural tissue can cause the adrenal gland to release catecholamines to treat hypoglycemia. In other embodiments, chemical, magnetic, optical, or mechanical neuromodulation can be used.
Claims39
A method of treating a disorder, comprising:
- placing a stimulation lead on neural tissue in communication with an adrenal gland;
- and
- delivering an electrical waveform from a neurostimulator to the stimulation lead to release catecholamines from the adrenal gland to treat hypoglycemia.
A method of treating a disorder in a patient, comprising:
- placing a stimulation lead on neural tissue in communication with an adrenal gland;
- measuring a glucose level of the patient with a continuous glucose monitor;
- and
- automatically applying an electrical waveform from the stimulation lead to the neural tissue when the glucose level is low to release catecholamines from the adrenal gland to treat hypoglycemia.
A system for stimulating an adrenal gland, comprising:
- a continuous glucose monitor configured to measure a patient glucose level;
- a stimulation lead;
- and
- an adrenal stimulator in communication with the continuous glucose monitor and the stimulation lead, the adrenal stimulator configured to apply an electrical waveform to the stimulation lead in response to the measured patient glucose level.
Dependencies are inferred from the claim text.